Starting January 1, 2025, most Blue Shield commercial members using Fresenius Kabi's adalimumab-aacf (a Humira biosimilar) ...

A federal judge in New York has ruled that Amgen must answer to claims of misleading investors about billions owed to US tax ...

Seven new clinical trial grants were awarded under the Orphan Product Grants Program during the fiscal year (FY) 2024, ...

The month-long standoff between the US Health Resources and Services Administration (HRSA) and Johnson & Johnson came to an ...

A functional point of contact (FPOC) is a dedicated liaison in each functional area responsible for evaluating and ...

UCB taps new UK head. Belgium-based global biopharmaceutical company UCB welcomed Nico Reynders as its new general manager ...

Cambridge, Massachusetts-based biotech Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors for the ...

The Securities & Exchange Commission (SEC) has accused Cassava's founder and former chief executive Remi Barbier and former ...

AI has the power to conduct these administrative tasks that pharmacists undertake. AI can help pharmacists intervene in a ...

Chiesi’s strategy aligns with EU priorities on innovation, security, and private R&D investment: the decision to establish a ...

Rebecca Douglas is a strategic leader with a passion for nurturing talent. With an award-winning track record in developing ...

Aqneursa has been approved to treat neurological symptoms associated with NPC in children and adults who weigh at least 15kg, ...